Huron Capital Completes Acquisition of Lab Crafters

Based in Ronkonkoma, New York, Lab Crafters has a strong reputation as a premium brand in a highly specialized market, building close relationships with its loyal, highly respected customer base.

“Lab Crafters offers competitive, differentiated products to its customers,” said Brian Walker, Partner of Strategic Leadership at Huron Capital. “The company has already gained meaningful share in the laboratory furniture market, and its loyal customers include some of the nation’s largest Fortune 500 companies and premier research institutions. Huron has invested in Lab Crafters because we believe the company is capable of accelerated growth and we are focused on pursuing a number of strategic initiatives to diversify and expand this runway.”

Walker, a former CEO of Herman Miller, will serve as a member of Lab Crafters board of directors. Founder Robert DeLuca, Sr. will continue to lead the company as CEO, and Robert DeLuca, Jr. will continue to operate as President.

“We are proud to have built Lab Crafters into one of the leading manufacturers of specialized furniture for laboratories in the U.S.,” DeLuca, Sr. said. “We are confident that our partnership with Huron will provide the necessary capital and industry expertise to further accelerate our national growth while we continue to serve our existing customers.”

Robert DeLuca, Sr. and his management team have developed Lab Crafters into a company that is well respected by its customers, makes products that are increasingly sought after by the market, and is ultimately poised for growth,” said Huron Capital Partner Scott Hauncher. “We are excited about Lab Crafters future and pleased to welcome the company to our firm as its newest platform.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version